PGP and chronic myelogenous leukemia, BCR-ABL1 positive: Particularly in chronic myeloid leukemia (CML), P-gp overexpression directly correlates with treatment failure [66,70,173], underscoring the necessity for effective modulation strategies in this and other hematological malignancies where P-gp-mediated resistance is a significant obstacle.